Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. Zhu CS, et al. Among authors: fung et. Cancer Prev Res (Phila). 2011 Mar;4(3):375-83. doi: 10.1158/1940-6207.CAPR-10-0193. Cancer Prev Res (Phila). 2011. PMID: 21372037 Free PMC article.
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.
Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY, Pfeiffer RM. Moore LE, et al. Among authors: fung et. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1641-6. doi: 10.1158/1055-9965.EPI-05-0980. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985025
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Clarke CH, Yip C, Badgwell D, Fung ET, Coombes KR, Zhang Z, Lu KH, Bast RC Jr. Clarke CH, et al. Among authors: fung et. Gynecol Oncol. 2011 Sep;122(3):548-53. doi: 10.1016/j.ygyno.2011.06.002. Epub 2011 Jun 25. Gynecol Oncol. 2011. PMID: 21708402 Free PMC article.
Proteomic approaches to tumor marker discovery.
Rai AJ, Zhang Z, Rosenzweig J, Shih IeM, Pham T, Fung ET, Sokoll LJ, Chan DW. Rai AJ, et al. Among authors: fung et. Arch Pathol Lab Med. 2002 Dec;126(12):1518-26. doi: 10.5858/2002-126-1518-PATTMD. Arch Pathol Lab Med. 2002. PMID: 12456215 Free article.
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer.
Høgdall C, Fung ET, Christensen IJ, Nedergaard L, Engelholm SA, Petri AL, Risum S, Lundvall L, Yip C, Pedersen AT, Hartwell D, Lomas L, Høgdall EV. Høgdall C, et al. Among authors: fung et. Gynecol Oncol. 2011 Nov;123(2):308-13. doi: 10.1016/j.ygyno.2011.07.018. Epub 2011 Aug 19. Gynecol Oncol. 2011. PMID: 21855971
67 results